Key Takeaways
- Strategic investments and targeted price increases are expected to drive revenue growth and expand margins, enhancing market share.
- Focus on high-margin segments and innovation is aimed at long-term earnings growth and improved shareholder value.
- Soft demand and macroeconomic challenges, including rising costs and interest rates, could pressure Sherwin-Williams' sales growth, margins, and net income.
Catalysts
About Sherwin-Williams- Engages in the development, manufacture, distribution, and sale of paint, coatings, and related products to professional, industrial, commercial and retail customers.
- The company expects to significantly outperform the market when demand returns, driven by strategic investments in sales reps, training, and digital tools, which should lead to increased revenue and market share gains in key segments like residential repaint and packaging.
- Sherwin-Williams plans to implement targeted price increases across its segments, which are expected to offset rising raw material costs and help in expanding gross margins, thus positively impacting earnings.
- The company is focusing on new account wins and continued share gains, specifically in the coil and packaging segments, which are expected to drive revenue growth and improve the overall margin mix due to the higher-margin nature of these products.
- Investments in their new headquarters and R&D center, alongside continuous innovation in high-margin product lines, are expected to enhance operational efficiencies and stimulate revenue growth, thereby supporting long-term earnings expansion.
- Sherwin-Williams anticipates delivering above-market growth through enterprise-wide efforts in talent acquisition, supply chain responsiveness, and sustainability initiatives, which are aimed at improving net margins and driving consistent shareholder value over time.
Sherwin-Williams Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?- This narrative explores a more optimistic perspective on Sherwin-Williams compared to the consensus, based on a Fair Value that aligns with the bullish cohort of analysts.
- The bullish analysts are assuming Sherwin-Williams's revenue will grow by 4.9% annually over the next 3 years.
- The bullish analysts assume that profit margins will increase from 11.6% today to 14.4% in 3 years time.
- The bullish analysts expect earnings to reach $3.9 billion (and earnings per share of $15.77) by about April 2028, up from $2.7 billion today. The analysts are largely in agreement about this estimate.
- In order for the above numbers to justify the price target of the more bullish analyst cohort, the company would need to trade at a PE ratio of 32.5x on those 2028 earnings, up from 30.1x today. This future PE is greater than the current PE for the US Chemicals industry at 17.5x.
- Analysts expect the number of shares outstanding to decline by 1.01% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 6.99%, as per the Simply Wall St company report.
Sherwin-Williams Future Earnings Per Share Growth
Risks
What could happen that would invalidate this narrative?- Soft demand in core markets could lead to lower-than-expected growth in sales, impacting overall revenue for the company.
- Uncertain macroeconomic conditions, including rising interest rates and slow recovery in housing markets, may hinder Sherwin-Williams' ability to realize its projected earnings growth in 2025, affecting earnings.
- Volatility in raw material costs, including potential tariff implementations and related price increases, could constrain margins and lower net margins.
- Elevated SG&A and building transition expenses could pressure net profitability despite modest increases in sales.
- Potential headwinds from foreign exchange fluctuations and increased interest expenses due to refinancing at higher rates may reduce net income and overall financial performance.
Valuation
How have all the factors above been brought together to estimate a fair value?- The assumed bullish price target for Sherwin-Williams is $423.0, which is the highest price target estimate amongst analysts. This valuation is based on what can be assumed as the expectations of Sherwin-Williams's future earnings growth, profit margins and other risk factors from analysts on the bullish end of the spectrum.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $423.0, and the most bearish reporting a price target of just $247.0.
- In order for you to agree with the bullish analysts, you'd need to believe that by 2028, revenues will be $26.7 billion, earnings will come to $3.9 billion, and it would be trading on a PE ratio of 32.5x, assuming you use a discount rate of 7.0%.
- Given the current share price of $322.81, the bullish analyst price target of $423.0 is 23.7% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
How well do narratives help inform your perspective?
Disclaimer
AnalystHighTarget is an employee of Simply Wall St, but has written this narrative in their capacity as an individual investor. AnalystHighTarget holds no position in NYSE:SHW. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. This narrative is general in nature and explores scenarios and estimates created by the author. The narrative does not reflect the opinions of Simply Wall St, and the views expressed are the opinion of the author alone, acting on their own behalf. These scenarios are not indicative of the company's future performance and are exploratory in the ideas they cover. The fair value estimate's are estimations only, and does not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that the author's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Read more narratives
